punuoan (ambrisentan tablets)-比较正规的买球软件

中

比较正规的买球软件-买球软件推荐-买球app软件 english

about us
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
news
- company news
- media focus
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
products
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
r&d
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
services
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
contact us
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.

punuoan (ambrisentan tablets)

ambrisentan tablets

english name: ambrisentan tablets

chinese pinyin: anlishengtanpian

the main ingredient of this product is ambrisentan

chemical name: ( )-(2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid

/en/upload/images/2018/10/10/e6e157a874bf4876b2e5e3caa55c0545.png

【name】	common name: ambrisentan english name: ambrisentan tablets chinese pinyin: anlishengtanpian
【ingredient】	the main ingredient of this product is ambrisentan chemical name: ( )-(2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid chemical structure： molecular formula: c22h22n2o4 molecular weight: 378.42
【description】	this product is a yellow film-coated tablet, which is white or off-white after removal of the film coat.
【indication】	this product is indicated for the treatment of patients with pulmonary arterial hypertension of who class ii-iii symptoms (who group 1) to improve exercise ability and delay clinical worsening. studies establishing effectiveness of ambrisentan included patients with etiologies of idiopathic or heritable pah (64%) or pah associated connective tissue disease (32%).
【strength】	5mg
【dosage and administration】	treatment with this drug must be initiated and supervised by up physician experienced in the treatment of pulmonary hypertension.